Pricing Log in Create free account

Geron Corporation (GERN) vs Immix Biopharma, Inc. (IMMX)

Geron Corporation and Immix Biopharma, Inc. are both Biotechnology companies. Geron Corporation and Immix Biopharma, Inc. are of similar size ($610.4M and $596.9M). Immix Biopharma, Inc. has the higher net margin (0.00% vs −22.0%) and the higher return on invested capital (0.00% vs −34.1%). Across the 13 metrics below, Immix Biopharma, Inc. leads on 8 and Geron Corporation on 5.

Valuation

Metric GERN IMMX Biotechnology median
P/E n/m n/m 10.60
P/S 3.03 n/m 9.40
P/B 2.91 2.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.59 n/m 9.02
Earnings yield (7.49%) (10.97%) (32.88%)
Free cash flow yield (13.84%) (7.64%) (23.13%)

Profitability

Metric GERN IMMX Biotechnology median
Gross margin 91.59% — 68.51%
Operating margin (14.75%) 0.00% 0.00%
Net margin (21.99%) 0.00% 0.00%
Free cash flow margin (41.91%) 0.00% 0.00%
Return on equity (20.12%) (34.18%) (51.96%)
Return on assets (8.74%) (31.34%) (46.06%)
Return on invested capital (34.12%) 0.00% 0.00%

Growth

Metric GERN IMMX Biotechnology median
Revenue growth (TTM) 18.60% — 6.76%
EPS growth (last fiscal year) 51.85% (17.11%) 29.88%
Revenue growth, 5-year CAGR 273.49% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GERN IMMX Biotechnology median
Debt to equity 0.53 0.00 0.00
Current ratio 6.31 25.13 4.97
Net debt to EBITDA 3.28 3.39 1.01

Dividend

Metric GERN IMMX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GERN IMMX Biotechnology median
Market cap 610.41m 596.90m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack